SB 239063 25mg
SB 239063 is a potent and selective p38 MAP kinase inhibitor (IC50 = 44 nM for p38??). SB 239063 displays > 220-fold selectivity over ERK, JNK1 and other kinases; ~ 3-fold more selective than SB 203580. SB 239063 reduces inflammatory cytokine production and is neuroprotective following oral administration in vivo.
| Trivial name | SB 239063 25mg |
| Catalog Number | A11562-25 |
| Alternative Name(s) | trans-1-(4-Hydroxycyclohexyl)-4-(4-fluorophenyl)-5-(2-methoxypyridimidin-4-yl)imidazole |
| Molecular Formula | C20H21FN4O2 |
| CAS# | 193551-21-2 |
| SMILES | COC1=NC=CC(=N1)C2=C(N=CN2C3CCC(CC3)O)C4=CC=C(C=C4)F |
| Size | 25mg |
| Supplier Page | http://www.adooq.com/sb-239063.html |